Unicycive Therapeutics, Inc., (UNCY): Price and Financial Metrics

Unicycive Therapeutics, Inc., (UNCY): $0.51

0.02 (+5.03%)

POWR Rating

Component Grades

Momentum

B

Stability

D

Sentiment

Quality

C

Add UNCY to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#171 of 333

in industry

UNCY Price/Volume Stats

Current price $0.51 52-week high $1.82
Prev. close $0.49 52-week low $0.20
Day low $0.47 Volume 1,688,500
Day high $0.55 Avg. volume 1,228,983
50-day MA $0.44 Dividend yield N/A
200-day MA $0.78 Market Cap 52.87M

UNCY Stock Price Chart Interactive Chart >


Unicycive Therapeutics, Inc., (UNCY) Company Bio


Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.


UNCY Latest News Stream


Event/Time News Detail
Loading, please wait...

UNCY Latest Social Stream


Loading social stream, please wait...

View Full UNCY Social Stream

UNCY Price Returns

1-mo 18.33%
3-mo 34.92%
6-mo -46.08%
1-year -12.07%
3-year -79.52%
5-year N/A
YTD -41.22%
2023 60.69%
2022 -73.79%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!